Is SYK Overvalued? DCF Says Worth $206

07:32am, Tuesday, 12'th May 2026
On May 12, 2026, we present a DCF analysis for Stryker Corp (SYK), a company that has faced notable price performance challenges recently, with a year-to-date d
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology com
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders
Stryker Corporation  (NYSE:SYK) shares are trading sideways on Monday. But that wasn't the case on Friday.
SYK misses Q1 earnings and revenue estimates as a cyber incident disrupts production, dents margins, and slows growth despite gains across key segments.
Portage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at
Organic Sales Growth: 2.4% worldwide, 1.9% in the US, 3.9% internationally.Adjusted Earnings Per Share (EPS): $2.60, down 8.5% from the previous year.Adjusted
Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript
While the top- and bottom-line numbers for Stryker (SYK) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to
Stryker (SYK) came out with quarterly earnings of $2.6 per share, missing the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.84 per share a year ago.
U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit ​and revenue, weighed down by softer demand for implan
The medical-device company posted a profit of $745 million, up from $654 million in the same quarter a year ago.
Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billi
Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.
SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE